Viewing Study NCT06588660


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-03-01 @ 8:59 PM
Study NCT ID: NCT06588660
Status: TERMINATED
Last Update Posted: 2025-07-29
First Post: 2024-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Sponsor: University of Washington
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Multiple Myeloma View
None Refractory Multiple Myeloma View
Keywords: